Why the study?
Spacer sequences were being lost from guide arrays used for dynamic silencing in the E. coli CRISPR Cascade system.
Basal Cas1/2 endonuclease activity causes loss of spacers from guide arrays in E. coli, which can be mitigated by using an inducible promoter.
Inducible Cascade control may stabilize guide arrays in bacterial CRISPR systems; leaves open translation to therapeutic gene circuits.
CRISPR-based interference has become common in various applications from genetic circuits to dynamic metabolic control. In E. coli, the native CRISPR Cascade system can be utilized for silencing by deletion of the cas3 nuclease along with expression of guide RNA arrays, where multiple genes can be silenced from a single transcript. We notice the loss of spacer sequences from guide arrays utilized for dynamic silencing. We report that unstable guide arrays are due to expression of the Cas1/2 endonuclease complex. We propose a model wherein basal Cas1/2 endonuclease activity results in the loss of spacers from guide arrays. Subsequently, mutant guide arrays can be amplified through selection. Replacing a constitutive promoter driving Cascade complex expression with a tightly controlled inducible promoter improves guide array stability, while minimizing leaky gene silencing. Additionally, these results demonstrate the potential of Cas1/2 mediated guide deletion as a mechanism to avoid CRISPR based autoimmunity.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: